Find Clinical Trial

Efficacy of Detralex® in Edema Treatment. An open, 6-month, multicentre study. EDET Study


← Back
Study Phase

Phase 4

Therapeutic Area

Cardiovascular Diseases

Indicationvenous disease
SponsorServier s.r.o.
Active substance/
Medical device

MICRONISED PURIFIED FLAVONOID FRACTION,
S005682

Active Substance CodeS005682
Protocol CodeIC4-05682-099
EudraCT Code2006-005721-28


Documents and links

Scientific publication READ MORE




Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.



© 2024 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
Accessibility